109,808 Shares in Corteva, Inc. $CTVA Acquired by Night Squared LP

Night Squared LP acquired a new position in Corteva, Inc. (NYSE:CTVA) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 109,808 shares of the company’s stock, valued at approximately $7,360,000. Corteva comprises approximately 2.1% of Night Squared LP’s holdings, making the stock its 18th largest position.

A number of other hedge funds have also recently added to or reduced their stakes in CTVA. Drummond Knight Asset Management Pty Ltd acquired a new position in Corteva during the fourth quarter valued at approximately $25,713,000. Alberta Investment Management Corp acquired a new position in Corteva during the third quarter valued at approximately $5,018,000. Avior Wealth Management LLC grew its holdings in Corteva by 464.7% during the fourth quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock valued at $2,205,000 after purchasing an additional 27,075 shares during the last quarter. HighTower Advisors LLC grew its holdings in Corteva by 8.6% during the third quarter. HighTower Advisors LLC now owns 182,643 shares of the company’s stock valued at $12,352,000 after purchasing an additional 14,436 shares during the last quarter. Finally, Arbejdsmarkedets Tillaegspension acquired a new position in Corteva during the fourth quarter valued at approximately $23,679,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Up 1.5%

CTVA opened at $76.84 on Wednesday. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $85.63. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $51.39 billion, a price-to-earnings ratio of 45.20, a P/E/G ratio of 2.32 and a beta of 0.57. The business has a 50 day moving average of $80.02 and a 200-day moving average of $75.52.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the prior year, the business earned $1.13 earnings per share. Corteva’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s dividend payout ratio is currently 42.35%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Wells Fargo & Company increased their price target on Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, April 21st. Berenberg Bank increased their price target on Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. Citigroup increased their price target on Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Argus increased their price target on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a report on Tuesday, March 31st. Finally, CICC Research increased their price target on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.81.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.